Member Login
  1. Stocks
    2. /
  2. Pfizer Inc. (NYSE: PFE)
    3. /

NYSE:PFE (Pfizer Inc.)

About PFE

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Pfizer Inc. (NYSE: PFE) Latest News

    Investing Articles

    Down 50% with a 6.5% yield, is this massive S&P 500 stock a screaming buy?

    | Mark Hartley

    Our writer considers the prospects of a once-massive S&P 500 stock that's fallen out of favour and now has a…

    Read more »

    Investing Articles

    2 shares for value investors to consider buying

    | Stephen Wright

    Investors looking for value shares might want to consider 3i and Pfizer as stocks that aren’t getting the attention they…

    Read more »

    Investing Articles

    2 quality income shares that are on sale right now

    | Stephen Wright

    Buying quality shares at discount prices is the way to generate a lasting passive income. So where are the opportunities…

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer
    Investing Articles

    The falling Croda International share price is getting difficult to ignore

    | Stephen Wright

    The Croda International share price is at its lowest level since 2017. It’s a quality business, but is this a…

    Read more »

    Investing Articles

    2 dividend growth shares I’ve just bought for my Stocks and Shares ISA

    | Stephen Wright

    Stephen Wright's been looking beyond the UK for dividend shares in the last couple of weeks. Here are the opportunities…

    Read more »

    Young black colleagues high-fiving each other at work
    Investing Articles

    £10,000 in savings? I’d buy these 2 dividend shares to hold for a decade of passive income

    | Stephen Wright

    Stephen Wright thinks dividend shares are unbeatable for income investors. He has a UK drinks firm and a US pharma…

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer
    Investing Articles

    With £1,000, I’d buy 45 shares of this unloved dividend stock for a passive income boost

    | Stephen Wright

    Despite falling vaccine sales, Stephen Wright thinks there’s a great passive income opportunity with Pfizer shares below pre-pandemic levels.

    Read more »

    Investing Articles

    3 healthcare dividend stocks to consider for passive income in 2024

    | Ben McPoland

    Our writer takes a look at three dividend stocks from the US and UK that could provide attractive passive income…

    Read more »

    Young female analyst working at her desk in the office
    Investing Articles

    A 6% yield but down 48%! Is this value stock now too cheap to ignore?

    | Stephen Wright

    As demand for Covid-19 vaccines wears off in 2023, Pfizer shares are down 48%. Stephen Wright thinks the stock looks…

    Read more »

    HEALTH in toy blocks with the text “Investing in Healthcare Top UK Healthcare Stocks” and The Motley Fool jester cap logo
    Page

    Investing in Healthcare: Top UK Healthcare Stocks of 2025

    | Zaven Boyrazian, MSc (TMFBoyrazian)

    Thinking of investing in healthcare in 2025? Discover an explosive multi-trillion-dollar industry among the top UK healthcare stocks!

    Read more »

    Scientist filling a needle
    Investing Articles

    3 reasons why Pfizer (NYSE:PFE) might be a great buy

    | Stephen Wright

    Pfizer stock has struggled this year, while other pharmaceutical companies have done well. Should our author be looking at buying…

    Read more »

    Businessman touching on number 2022 for preparation
    Investing Articles

    3 US stocks to buy for 2022

    | Rupert Hargreaves

    These could be some of the best US stocks to buy for 2022 and beyond, says Rupert Hargreaves, who would…

    Read more »